Description
+ Include: videos + file sub vtt + pdf, size: GB
+ Target Audience: physicians, fellows, residents, physician assistants, nurse practitioners, nurses, and all healthcare providers with an interest in electrophysiology
+ Sample video: contact me for sample video
+ Information:
Join us for Cleveland Clinic’s Global EP Summit 2026.
Cleveland Clinic’s 8th Annual Global EP Summit 2026 is a two-day symposium to discuss innovations in devices, techniques, recent clinical trials, and current guidelines in cardiac electrophysiology. Topics include updates on catheter ablation, stroke prevention in atrial fibrillation, ventricular arrhythmia ablation, new frontiers in pacing and lead management, and sudden cardiac death and CHD. This meeting will provide attendees with a thorough and practical course on the current state of the art in the field and provide an opportunity for both faculty and attendees to interact in a forum which will encourage an open discussion of arrhythmia management, perceived challenges, and future directions.
After completing this activity, participants will be able to:
- Evaluate and apply contemporary catheter ablation strategies for ventricular arrhythmias by incorporating pre-procedural MRI and CT for VT circuit identification, assessing the feasibility and outcomes of substrate-based VT ablation without VT induction, interpreting early clinical lessons from pulsed field ablation for ventricular arrhythmias, and selecting mapping and ablation approaches for challenging idiopathic ventricular arrhythmia sites and ventricular fibrillation triggers or substrate.
- Integrate and evaluate emerging evidence and new technologies for the prevention, detection, risk assessment, rhythm and rate management, and stroke prevention into the care of patients with atrial fibrillation.
- Assess candidacy for ventricular tachycardia ablation in high-risk patients, appraise the current and emerging roles of cardiac radio-ablation and cardiac sympathetic denervation for refractory VT/VF, and apply multidisciplinary clinical reasoning to complex ventricular arrhythmia cases to guide individualized management decisions.
- Apply an individualized approach to atrial fibrillation management by integrating evolving AF classification concepts, atrial myopathy assessment, heart failure and sleep apnea comorbidity considerations, obesity management strategies, and continuous monitoring data to inform the timing and selection of AF ablation.
- Discuss strategies to improve treatment outcomes in patients with ventricular arrhythmias and structural heart disease, including new ablation techniques and technologies.
- Evaluate diverse causes of sudden cardiac death across congenital heart disease, younger patient populations, and inherited channelopathies, and apply a systematic diagnostic approach to postural orthostatic tachycardia syndrome to improve risk assessment, differential diagnosis, and management planning.
Who Should Attend?
The course is directed to physicians, fellows, residents, physician assistants, nurse practitioners, nurses, and all healthcare providers with an interest in electrophysiology.
+ Topics:
Friday, September 18
|
|
|
7:00 AM
|
Registration & Breakfast |
|
7:30 AM
|
Welcome and Announcements Oussama Wazni, MD, MBA |
|
7:35 AM
|
Heart Rhythm Society Update Sana Al-Khatib, MD |
|
7:45 AM
|
Top EP Publications in 2026 and What to Look for in 2027 Kalyanam Shivkumar, MD, PhD |
Session 1 – Ventricular Arrhythmia Ablation
|
|
|
8:00 AM
|
Identification of VT Circuit with Pre-Procedural Cardiac Imaging (MRI and CT) Jeffrey Winterfield, MD |
|
8:10 AM
|
Substrate-Based VT Ablation with No VT Induction: Feasibility and Outcomes Andre D’Avila, MD |
|
8:20 AM
|
Early US Clinical Experience with PFA for Ventricular Arrhythmias – Lessons Learned Pasquale Santangeli, MD, PhD |
|
8:30 AM
|
Mapping and Ablation of Challenging Idiopathic Ventricular Arrhythmia Locations: Intracavitary Structures, Para-Hisian Locations, Epicardial Koji Higuchi, MD, PhD |
|
8:40 AM
|
Ablation of Ventricular Fibrillation – Ablation of Trigger or Ablation of Substrate Jakub Sroubek, MD, PhD |
|
8:50 AM
|
Panel Discussion/Q&A Session Faculty |
|
9:10 AM
|
Break |
Part 2: Bailout Strategies for Refractory Cases
|
|
|
9:20 AM
|
When to Say No to VT Ablation? Identifying the Highest Risk Patient Jakub Sroubek, MD, PhD |
|
9:30 AM
|
Cardiac Radioablation for Refractory VT – The Cleveland Clinic Experience Justin Lee, MD |
|
9:40 AM
|
Cardiac Sympathetic Denervation for VT/VF – Current Role and Future Directions Olujimi Ajijola, MD, PhD |
|
9:50 AM
|
CCF Fellow Presents Challenging VT Case and Panel Discussion Panelists: Olujimi Ajijola, MD, PhD, Roy Chung, MD, Andre D’Avila, MD, Koji Higuchi, MD, PhD, Justin Lee, MD, Pasquale Santangeli, MD, PhD, Jeffrey Winterfield, MD |
|
10:00 AM
|
Panel Discussion/Q&A Session Faculty |
|
10:20 AM
|
Break |
Session 2 – Clinical AF Management
|
|
|
10:30 AM
|
It is time to Change AF Classification System Nassir Marrouche, MD |
|
10:40 AM
|
Understanding Atrial Myopathy: A Personalized Approach to AF Ablation Nazem Akoum, MD, MS |
|
10:50 AM
|
AF Ablation in Advanced Heart Failure Philipp Sommer, MD |
|
11:00 AM
|
Sleep Apnea and AF, VT, CHF Michael Faulx, MD |
|
11:10 AM
|
AF in Obesity? Why Can’t I Use Ozempic? Leslie Cho, MD |
|
11:20 AM
|
Update on Castle II Study Nassir Marrouche, MD |
|
11:30 AM
|
How Early Should We Ablate AF, Insights from Continuous Monitoring Jason Andrade, MD |
|
11:40 AM
|
First Line Ablation for Persistent AF Oussama Wazni, MD, MBA |
|
11:50 AM
|
Panel Discussion/Q&A Session Faculty |
|
12:10 PM
|
Lunch & Optional Non-CME Satellites |
Session 3 – Stroke Prevention
|
|
|
1:10 PM
|
AF Screening: Who, When and How? Abbas Kharal, MD, MPH |
|
1:20 PM
|
Personalized and Targeted Stroke Prevention Shazam Hussain, MD |
|
1:30 PM
|
Future Directions in Stroke Prevention: Surgical, Catheter based, Adjunctive OAC and LAAO Jeff Healey, MD |
|
1:40 PM
|
ICE Guided Combined AF Ablation + LAAO Frank Cuoco, MD |
|
1:50 PM
|
Welcome to the Real World of LAA Closure: Challenges and Triumphs Walid Saliba, MD |
|
2:00 PM
|
Reverse Option Chenyang Jiang, MD |
|
2:10 PM
|
New Devices: LAAO Devices Devi Nair, MD |
|
2:20 PM
|
Panel Discussion/Q&A Session Faculty |
Session 4 – Hot Topics in AF Ablation
|
|
|
2:40 PM
|
New PFA Catheters (Sphere 360, Faraflex, Volt, etc.) DJ Lakkireddy, MD |
|
2:50 PM
|
Lesion Prediction in PFA Hiroshi Nakagawa, MD, PhD |
|
3:00 PM
|
Novel Large Footprint PFA Catheters: Early Experience Ante Anic, MD |
|
3:10 PM
|
Update on Clinical Outcomes with PFA of Atrial Arrhythmias: Clinical Trials and Real-World Data Moussa Mansour, MD |
|
3:20 PM
|
Atypical Atrial Flutters (AFL) Ablation: Impact of PFA Ayman Hussein, MD |
|
3:30 PM
|
Panel Discussion/Q&A Session Faculty |
|
3:50 PM
|
Break |
Session 5 – Mapping in AF
|
|
|
4:00 PM
|
Maximizing Success for Persistent AF Ablation: Empiric Ablation or Mapping Andrea Natale, MD |
|
4:10 PM
|
Mapping of AF: Is it Needed? Why and When? Mandeep Bhargava, MD |
|
4:20 PM
|
Cortex (Overview Tech and Case Presentation) Vivek Reddy, MD |
|
4:30 PM
|
Carto Finder Luigi DiBiase, MD, PhD |
|
4:40 PM
|
vMap in Clinical Practice: Technology Overview and Use Cases Devi Nair, MD |
|
4:50 PM
|
Panel Discussion/Q&A Session Faculty |
Session 6 – THE GREAT DEBATE
|
|
|
5:10 PM
|
OCEAN! No Need for Anything Atul Verma, MD |
|
5:20 PM
|
OPTION! Close it and Forget About it Vivek Reddy, MD |
|
5:30 PM
|
Rebuttals Atul Verma, MD and Vivek Reddy, MD |
|
5:50 PM
|
Day 1 Adjourn |





Reviews
There are no reviews yet.